Genesis IBRC India [GENESIS] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

Genesis IBRC India

BSE
Loading...

Panacea Biotec

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Genesis IBRC India wins in 9 metrics, Panacea Biotec wins in 8 metrics, with 0 ties. Genesis IBRC India appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGenesis IBRC IndiaPanacea BiotecBetter
P/E Ratio (TTM)29.47222.06Genesis IBRC India
Price-to-Book Ratio10.233.03Panacea Biotec
Debt-to-Equity Ratio0.002.67Genesis IBRC India
PEG Ratio1.03-1.77Panacea Biotec
EV/EBITDA29.57-195.08Panacea Biotec
Profit Margin (TTM)94.96%1.88%Genesis IBRC India
Operating Margin (TTM)94.96%-5.74%Genesis IBRC India
EBITDA Margin (TTM)94.96%N/AN/A
Return on Equity41.08%-1.01%Genesis IBRC India
Return on Assets (TTM)39.67%-0.65%Genesis IBRC India
Free Cash Flow (TTM)$-3,000$-776.74MGenesis IBRC India
1-Year Return330.64%32.45%Genesis IBRC India
Price-to-Sales Ratio (TTM)28.004.17Panacea Biotec
Enterprise Value$1.04B$24.56BPanacea Biotec
EV/Revenue Ratio28.264.03Panacea Biotec
Gross Profit Margin (TTM)N/A53.68%N/A
Revenue per Share (TTM)$3$100Panacea Biotec
Earnings per Share (Diluted)$2.68$1.87Genesis IBRC India
Beta (Stock Volatility)0.540.30Panacea Biotec
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Genesis IBRC India vs Panacea Biotec Stock Performance Analysis

Loading Price Chart...

Genesis IBRC India
Panacea Biotec
Genesis IBRC India Stock Overview | Panacea Biotec Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Genesis IBRC India5.00%21.53%107.62%272.20%330.64%330.64%
Panacea Biotec3.06%-0.04%-2.22%-4.62%-10.01%-7.42%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Genesis IBRC India330.64%330.64%907.40%907.40%907.40%907.40%
Panacea Biotec32.45%205.48%115.98%189.61%103.04%23.47%

News Based Sentiment: Genesis IBRC India vs Panacea Biotec

Genesis IBRC India

News based Sentiment: POSITIVE

Genesis IBRC India Ltd. experienced a remarkably positive month, achieving new all-time highs and demonstrating exceptional growth across multiple timeframes. The company's strong financial performance, coupled with its zero debt status, significantly strengthens its investment appeal and positions it for continued success.

View Genesis IBRC India News Sentiment Analysis

Panacea Biotec

News based Sentiment: MIXED

September presented a mixed bag for Panacea Biotec, with strong gains in some areas like vaccine development and product launches offset by conflicting financial reports and share price volatility. While the company is clearly making progress, the inconsistencies create uncertainty for investors, making this a significant but complex month.

View Panacea Biotec News Sentiment Analysis

Performance & Financial Health Analysis: Genesis IBRC India vs Panacea Biotec

MetricGENESISPANACEABIO
Market Information
Market Cap i₹1.03B₹26.29B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1236,929
90 Day Avg. Volume i4210,411
Last Close₹78.98₹427.95
52 Week Range₹15.85 - ₹78.98₹271.20 - ₹581.90
% from 52W High0.00%-26.46%
All-Time High₹78.98 (Oct 03, 2025)₹581.90 (Apr 28, 2025)
% from All-Time High0.00%-26.46%
Growth Metrics
Quarterly Revenue GrowthN/A0.44%
Quarterly Earnings GrowthN/A0.44%
Financial Health
Profit Margin (TTM) i0.95%0.02%
Operating Margin (TTM) i0.95%-0.06%
Return on Equity (TTM) i0.41%-0.01%
Debt to Equity (MRQ) i0.002.67
Cash & Liquidity
Book Value per Share (MRQ)₹7.72₹136.92
Cash per Share (MRQ)₹0.00₹17.95
Operating Cash Flow (TTM) i₹0₹-1,511,860,000
Levered Free Cash Flow (TTM) i₹35.05M₹-83,700,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Genesis IBRC India vs Panacea Biotec

MetricGENESISPANACEABIO
Price Ratios
P/E Ratio (TTM) i29.47222.06
Forward P/E iN/AN/A
PEG Ratio i1.03-1.77
Price to Sales (TTM) i28.004.17
Price to Book (MRQ) i10.233.03
Market Capitalization
Market Capitalization i₹1.03B₹26.29B
Enterprise Value i₹1.04B₹24.56B
Enterprise Value Metrics
Enterprise to Revenue i28.264.03
Enterprise to EBITDA i29.57-195.08
Risk & Other Metrics
Beta i0.540.30
Book Value per Share (MRQ) i₹7.72₹136.92

Financial Statements Comparison: Genesis IBRC India vs Panacea Biotec

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)GENESISPANACEABIO
Revenue/Sales i₹0₹1.67B
Cost of Goods Sold iN/A₹772.20M
Gross Profit iN/A₹894.80M
Research & Development iN/AN/A
Operating Income (EBIT) i₹-1.18M₹-95.70M
EBITDA i₹-1.18M₹44.90M
Pre-Tax Income i₹-1.18M₹65.60M
Income Tax i₹0₹26.00M
Net Income (Profit) i₹-1.18M₹39.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)GENESISPANACEABIO
Cash & Equivalents i₹57,000₹821.25M
Total Current Assets i₹88.35M₹5.45B
Total Current Liabilities i₹3.03M₹3.67B
Long-Term Debt iN/A₹150.00M
Total Shareholders Equity i₹85.33M₹8.31B
Retained Earnings i₹-83.06M₹7.80B
Property, Plant & Equipment iN/A₹5.43B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)GENESISPANACEABIO
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGENESISPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1236,929
Average Daily Volume (90 Day) i4210,411
Shares Outstanding i13.00M61.25M
Float Shares i577,64015.45M
% Held by Insiders i0.96%0.73%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: Genesis IBRC India vs Panacea Biotec

MetricGENESISPANACEABIO
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A